Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
1-(4-ethoxyphenyl)-5-methoxy-2-methyl-1H-indole-3-carboxylic acid → 1'-{[1-(4-Ethoxyphenyl)-5-methoxy-2-methyl-1H-indol-3-yl]carbonyl}-3H-spiro[2-benzofuran-1,4'-piperidin]-3-one
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | 1-(4-ethoxyphenyl)-5-methoxy-2-methyl-1H-indole-3-carboxylic acid | HCID 742160 | — |
| 반응물 | 3H-spiro(isobenzofuran-1,4'-piperidin)-3-one | HCID 9834255 | — |
| 생성물 | 1'-{[1-(4-Ethoxyphenyl)-5-methoxy-2-methyl-1H-indol-3-yl]carbonyl}-3H-spiro[2-benzofuran-1,4'-piperidin]-3-one | HCID 57978137 | — |
반응 단계
Following the general procedure I as described above, the acylation of 3H-spiro[2-benzofuran-1,4′-piperidin]-3-one prepared as described in example 16, with commercially available 1-(4-ethoxyphenyl)-5-methoxy-2-methyl-1H-indole-3-carboxylic acid, gave the title compound. ES-MS m/e (%): 511.5 (M+H+).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US07332501B2 |
| 출처 데이터셋 | uspto-grants-2008_02 |
| ORD ID | ord-364e5adf91544d4aa855e8187513f9b9 |
| 출처 메모 | uspto-grants-2008_02 |